Corcept Therapeutics Current Ratio 2010-2024 | CORT

Corcept Therapeutics current ratio for the quarter ending September 30, 2024 was 3.71.

  • Corcept Therapeutics average current ratio for 2023 was 4.83, a 37.35% decline from 2022.
  • Corcept Therapeutics average current ratio for 2022 was 7.71, a 8.21% decline from 2021.
  • Corcept Therapeutics average current ratio for 2021 was 8.4, a 19.15% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

Corcept Therapeutics Current Ratio 2010-2024 | CORT

  • Corcept Therapeutics average current ratio for 2023 was 4.83, a 37.35% decline from 2022.
  • Corcept Therapeutics average current ratio for 2022 was 7.71, a 8.21% decline from 2021.
  • Corcept Therapeutics average current ratio for 2021 was 8.4, a 19.15% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.